4893 items matching your search terms.

Process mapping to identify barriers and facilitators for the international translation of the Australian PCOS lifestyle management guideline recommendations

Ko, H. Moran, L. Viardot-Foucault, V. Tan, H. Teede, H.

Closing the gap between research, biobanks and clinical practice: a 12 month exploratory study into developing a standard pre-operative model for obtaining biobank consent

Koegelenberg, A.M. Dean, S. Meagher, N.S. Caruso, L. Goode, S. Pillai, U. Marsh, D.J. Brown, S. Walczak, A. Yip, S. Kench, J.G. Horvath, L. Nielsen, S. Hawkins, N.J. Scott, R.

Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29

Laurie, S. A. Solomon, B. J. Seymour, L. Ellis, P. M. Goss, G. D. Shepherd, F. A. Boyer, M. J. Arnold, A. M. Clingan, P. Laberge, F. Fenton, D. Hirsh, V. Zukin, M. Stockler, M. R. Lee, C. W. Chen, E. X. Montenegro, A. Ding, K. Bradbury, P. A.
EUROPEAN JOURNAL OF CANCER, 2014     DOI:10.1016/j.ejca.2013.11.032

Prognostic, predictive, and surrogate value of HER2 extracellular domain for progression-free survival in advanced breast cancer treated with lapatinib: a meta-analysis

Lee, C Davies, L Marschner, I Gebski, V Lord, S Di Leo, A Johnston, SRD Geyer, CE Cameron, DA Press, MF Ellis, CE Loi, S Simes, J De Souza, P

Demand for emergency department services in the elderly: an 11 year analysis of the Greater Sydney Area

Leonard, C. Bein, K.J. Latt, M. Muscatello, D. Veillard, A.S. Dinh, M.M.
EMERGENCY MEDICINE AUSTRALASIA, 2014     DOI:10.1111/1742-6723.12250

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

Lin, H. M. Castillo, L. Mahon, K. L. Chiam, K. Lee, B. Y. Nguyen, Q. Boyer, M. J. Stockler, M. R. Pavlakis, N. Marx, G. Mallesara, G. Gurney, H. Clark, S. J. Swarbrick, A. Daly, R. J. Horvath, L. G.
BRITISH JOURNAL OF CANCER, 2014     DOI:10.1038/bjc.2014.181

Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales

Linton, A. Pavlakis, N. O'Connell, R. Soeberg, M. Kao, S. Clarke, S. Vardy, J. van Zandwijk, N.
BRITISH JOURNAL OF CANCER, 2014     DOI:10.1038/bjc.2014.478

Emerging lipoprotein-related therapeutics for patients with diabetes

Little, P.J. Chait, A. Januszewski, A.S. Bobik, A. O'Neal, D. Jenkins, A.J.
, 2014     DOI:10.1007/978-1-4614-7554-5_17

Integration-free human induced pluripotent stem cells from type 1 diabetes patient skin fibroblasts show upregulations of pancreas-specific microRNAs

Liu, J. Joglekar, M.V. Sumer, H. Hardikar, A.A. Teede, H. Verma, P.J.
CELL MEDICINE, 2014     DOI:10.3727/215517914X681785

KI67 expression has prognostic significance in relation to human papillomavirus status in oropharyngeal squamous cell carcinoma

Liu, J. J. Zhang, M. Rose, B. Veillard, A. S. Jones, D. Lee, S. Hong, A.

Current clinician practices in utilising radiotherapy and targeted therapies in treating patients with metastatic renal cell carcinoma—a survey of Australian and New Zealand clinicians

Long, A Roncolato, F Foroudi, F. Goldstein, D. Davis, I. Siva, S.

P3 BEP: a randomised accelerated versus standard BEP chemotherapy for patients with intermediate and poor‐risk metastatic germ cell tumours (ANZUP protocol 1302)

Long, A Stockler, M Martin, A Roncolato, F Yeung, A Coskinas, X Goner, GC King, M Yip, S Thomson, DB Friedlander, M Quinn, D Singhal, N Grimison, PS

P3 BEP: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours

Long, A Stockler, M Martin, A Roncolato, F Yeung, A Coskinas, X Toner, GC King, M Yip, S Thomson, DB Friedlander, M Quin, D Singhal, N Grimison, PS

Management of patients with non-metastatic muscle invasive bladder cancer. A survey of clinicians’ practice

Long, A Stockler, M Sengupta, S.

The ANZUP phase 3 accelerated BEP trial: a randomised phase 3 trial of accelerated versus standard bep chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours

Long, A. Toner, G. C. Stockler, M. Thompson, D. B. Gebski, V. Yip, S. King, M. Friedlander, M. Quinn, D. Singhal, N. Roncolato, F. Grimison, P. S.